Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New formulations and alternative injection sites could allow people to administer the shots at home.
Most people in a pilot program at a safety-net HIV clinic achieved viral suppression on the long-acting injectable regimen.
Generic cabotegravir, an every-other-month injectable to prevent HIV, will arrive in select countries. WHO and Health Gap have opinions.
Under provisions of the Affordable Care Act, insurers must cover costs related to PrEP.
Currently, fewer than 1 in 10 women eligible for HIV prevention medications are taking them.
The long-acting regimen will enable some adolescents to take their HIV treatment just six times a year.
The every-other-month schedule of injectable cabotegravir plus rilpivirine enables some people to take HIV treatment just six times a year.
Using the new dosing schedule, injectable cabotegravir and rilpivirine can be administered just six times a year.
Every-other-month cabotegravir injections may work even better than daily pills for HIV prevention.
Starting today, the CDC recommends that clinicians prescribe pre-exposure prophylaxis to anyone who asks for it.
The long-acting injectable regimen suppressed HIV in more than 90% of study participants, including those with obesity.
Injections of cabotegravir given once every two months may work even better than daily pills for HIV prevention.
According to a recent study, transgender women might benefit more than they think from the prevention pill.
Awareness of the HIV prevention pills don’t match their use.
Injections given every month or every other month were preferred over daily pills.
Cabotegravir injections and daily Truvada are both highly effective, but some people may find it easier to use the long-acting regimen.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.